Nope, like I said, no one will take this on for depression yet... UNLESS it proves it works for Alzheimer's, then everyone will be on board for it, including for an anti-depression drug. (After all, drug companies are there to make money, and if this improves cognition for Alzheimer's sufferers, lots of companies will want to sell it to anyone they can.)
Ann: ACW updated depression trial results and implications, page-27
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $73.62M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.6¢ | 2.5¢ | $168.1K | 6.727M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2181218 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 3405501 | 14 |
View Market Depth
| Last trade - 11.53am 03/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |